Crinetics Pharmaceuticals (CRNX) Share-based Compensation (2017 - 2026)
Crinetics Pharmaceuticals (CRNX) reported Share-based Compensation of $24.88 million for Q2 2026, down 4.8% from $26.12 million a year earlier and down 16.2% from the prior quarter.
Powered by 
Analysis
Crinetics Pharmaceuticals (CRNX) Share-based Compensation (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Crinetics Pharmaceuticals' Share-based Compensation came in at $98.98 million, up 18.4% year-over-year; for FY2025, it was $91.02 million, up 31.2% from FY2024.
- Share-based Compensation has increased for nine consecutive years, with a five-year compound annual growth rate of 54.2% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $69.39 million in FY2024 (+69.5%), $40.94 million in FY2023 (+44.8%), $28.27 million in FY2022 (+62.9%) and $17.35 million in FY2021 (+66.4%).
- Five-year quarterly Share-based Compensation spans a low of $4.56 million in Q3 2021 and a high of $29.68 million in Q1 2026.
- Year over year, Share-based Compensation gained in seven of the last eight quarters, with growth averaging 37.1%.
- The high point for year-over-year Share-based Compensation in five years was Q2 2024 (growth of 86.1%); the low point was Q2 2026 (a decline of 4.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $29.68 million (Q1 2026), $21.72 million (Q4 2025) and $22.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Crinetics Pharmaceuticals | 8.99 Bn | 8.99 Bn | 24.96 Mn | 24.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.88 Mn |
| Mar 31, 2026 | 29.68 Mn |
| Dec 31, 2025 | 21.72 Mn |
| Sep 30, 2025 | 22.70 Mn |
| Jun 30, 2025 | 26.12 Mn |
| Mar 31, 2025 | 20.48 Mn |
| Dec 31, 2024 | 18.85 Mn |
| Sep 30, 2024 | 18.15 Mn |
| Jun 30, 2024 | 18.94 Mn |
| Mar 31, 2024 | 13.45 Mn |
| Dec 31, 2023 | 11.62 Mn |
| Sep 30, 2023 | 11.05 Mn |
| Jun 30, 2023 | 10.18 Mn |
| Mar 31, 2023 | 8.10 Mn |
| Dec 31, 2022 | 7.95 Mn |
| Sep 30, 2022 | 7.43 Mn |
| Jun 30, 2022 | 7.13 Mn |
| Mar 31, 2022 | 5.76 Mn |
| Dec 31, 2021 | 5.16 Mn |
| Sep 30, 2021 | 4.56 Mn |
API Access
Crinetics Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CRNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "CRNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CRNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();